Company Filing History:
4 out of 1,975 
2 out of 14 
1 out of 832,880 Years Active: 1999-2008
Title: Innovations of Lea Anne Harrington in the Field of Telomerase Research
Introduction
Lea Anne Harrington is a prominent inventor based in Toronto, Canada. With an impressive portfolio comprising five patents, Harrington's work primarily focuses on the intricate mechanisms of telomerase, a crucial enzyme associated with cellular aging and cancer. Her innovative contributions have significant implications for both diagnostics and therapeutic interventions in the field of molecular biology.
Latest Patents
Harrington's latest patents demonstrate her pioneering approach to telomerase research. One of her noteworthy inventions, titled "Polynucleotides Encoding a Telomerase Component TP2," discloses nucleic acid molecules that encode polypeptides of the telomerase complex. This patent elucidates methods for preparing these nucleic acid molecules and polypeptides, alongside various applications for their use.
Another significant contribution is her invention concerning "Selective Binding Agents of Telomerase." This patent relates to novel selective binding agents, including both polyclonal and monoclonal antibodies that specifically recognize and bind to the catalytic subunit of human telomerase (hTERT). The invention extends to the production, diagnostic, and therapeutic applications of these hTERT antibodies and their fragments.
Career Highlights
Throughout her career, Lea Anne Harrington has made remarkable strides in biomedicine. She has dedicated herself to researching telomerase, addressing critical aspects that could unlock new avenues for treatment in oncology. The depth of her expertise is reflected in her patents, which have garnered attention in scientific and medical communities.
Collaborations
During her journey, Harrington has had the opportunity to collaborate with esteemed professionals, including her coworker Murray O. Robinson. Their partnership highlights a shared commitment to advancing understanding in the complexities of telomerase and its implications for human health.
Conclusion
Lea Anne Harrington exemplifies innovation in the rapidly evolving field of molecular biology, particularly concerning telomerase. Her patents not only contribute to scientific knowledge but also pave the way for potential therapeutic solutions to complex diseases. As her work continues to influence her field, Harrington remains a vital figure in the quest for understanding the mechanisms of life at a cellular level.